Previous 10 | Next 10 |
Evolus (EOLS) has priced its public offering of 9M common shares at $9.50/share, for expected gross proceeds of $85.5M.Underwriters' over-allotment is an additional 1.35M shares.Net proceeds will be used to fund the U.S. growth of Jeuveau, European pre-launch activities and general corpo...
Gainers: [[XM]] +7.9%. [[CHDN]] +6.0%. [[IRDM]] +4.8%. [[UFPI]] +4.8%. [[SYBX]] +4.4%.Losers: [[EOLS]] -13.7%. [[AZN]] -7.9%. [[CBAY]] -6.6%. [[SNBR]] -6.0%. [[CENX]] -5.7%. For further details see: XM, IRDM, EOLS and AZN among after-hours movers
Evolus (EOLS) trades 3.2% down after hours on commencing a proposed underwritten public offering to issue and sell shares of its common stock; underwriters granted 30 days option to purchase up to an additional 15% of the shares.Offer size, terms not yet disclosed.Net proceeds to be...
Gainers: Greenlane (GNLN) +37%, SunLink Health Systems (SSY) +17%, Aquestive Therapeutics (AQST) +14%, Evolus (EOLS) +14%, Spectrum Pharmaceuticals (SPPI) +11%.Losers: 9 Meters Biopharma (NMTR) -22%, Delcath Systems (DCTH) -20%, Celsion (CLSN)...
Evolus ([[EOLS]] -1.0%) has filed for a mixed securities offering of $250M under the shelf registration process.The company says in a regulatory filing that from time to time it intends to sell common stock, preferred stock, warrants, or a combination of those at a price determined ...
The following slide deck was published by Evolus, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Evolus, Inc. 2020 Q4 - Results - Earnings Call Presentation
Gainers: ProQR Therapeutics (PRQR) +47%.Cellect Biotechnology (APOP) +47%.Houston Wire & Cable (HWCC) +38%.GameStop (GME) +29%.Koss (KOSS) +28%.Cinedigm (CIDM) +28%.F-star Therapeutics (FSTX) +26%.FreightCar America (RAIL) +24%.Polar Power (POLA) +20%.Immutep (IMMP) +20%.Losers:...
Evolus (EOLS) slides 10% premarket after announcing Q4 and FY20 results for period ended December 31, 2020.For Q4, the company recorded total net revenues of $20.6M, +5.8% Y/Y and a beat of $0.3M.Revenue was partially impacted by the company selling under a bond required by the ITC ...
Evolus, Inc. (EOLS) Q4 2020 Earnings Conference Call March 24, 2021 4:30 PM ET Company Participants Ashwin Agarwal – Vice President, Finance, Investor Relations and Treasurer David Moatazedi – President and Chief Executive Officer Lauren Silvernail – Chief Financial Offic...
Evolus (EOLS): Q4 GAAP EPS of -$3.28 misses by $2.94.Revenue of $20.58M (+5.8% Y/Y) beats by $0.28M.Cash, cash equivalents and short-term investments as of December 31, 2020 were $107.6 million.Pro forma cash position at December 31, 2020 was $57 million.Outlook: The company an...
News, Short Squeeze, Breakout and More Instantly...
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will host an Investor Day on Thursday, September 12, 2024 in New York City. Attendees can join in-person or participate via webcast. The even...
Launching into this growth market 1 as part of the company’s geographic expansion strategy Evolus Australia established to drive medical education, training, marketing and sales to medical aesthetics healthcare professionals Evolus, Inc. (NASDAQ: EOLS), a perf...
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that Sandra Beaver, CFO, will present at the following investor conference. Event: The Canaccord Genuity 44 th Annual Growth Conference Date: T...